Clinical Trials
2 trialsNCT06169579 2024-11-15
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
Shenzhen NewDEL Biotech, Co., Ltd
Phase 1 Enrolling by invitation
NCT06205082 2024-03-01
A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor
LittDD Medicines Ltd
Phase 1 Enrolling by invitation